NXP Semiconductors (NXPI) has been running up on rampant speculation that NXP Semiconductors is for sale. Now the CEO has come out and clearly stated that he is not shopping the company. The CEO also stated that he is looking to acquire another semiconductor company. We trade based on the
The drug from Xenoport (XNPT) is for moderate to severe Restless Leg Syndrome. This drug will compete with existing treatments IT is not clear if the drug presents an advantage compared to the existing treatments with the exception of a small number of patients. It does not appear that the
Investors bid up shares of Xenoport (XNPT) by 56% on approval of Horizant.The company will have difficulty generating profits to support this huge stock move. We are now short from $10.18. For more details of the rationale to short sell, target tzone, stop zone,and real time updates, check out ZYX SHORT SELL CHANGE